NDUFC1
gene geneOn this page
Also known as KFYI
Summary
NDUFC1 (NADH:ubiquinone oxidoreductase subunit C1, HGNC:7705) is a protein-coding gene on chromosome 4q31.1, encoding NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial (O43677). Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. It is a selective cancer dependency (DepMap: 16.5% of cell lines).
The encoded protein is a subunit of the NADH:ubiquinone oxidoreductase (complex I), the first enzyme complex in the electron transport chain located in the inner mitochondrial membrane. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 4717 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 24 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 16.5% of screened cell lines
- MANE Select transcript:
NM_001184989
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:7705 |
| Approved symbol | NDUFC1 |
| Name | NADH:ubiquinone oxidoreductase subunit C1 |
| Location | 4q31.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KFYI |
| Ensembl gene | ENSG00000109390 |
| Ensembl biotype | protein_coding |
| OMIM | 603844 |
| Entrez | 4717 |
Gene structure
Transcript identifiers
Ensembl transcripts: 67 — 62 protein_coding, 4 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000394223, ENST00000394225, ENST00000394228, ENST00000503453, ENST00000503997, ENST00000505036, ENST00000507764, ENST00000513022, ENST00000539002, ENST00000539387, ENST00000544855, ENST00000676245, ENST00000854294, ENST00000854295, ENST00000854296, ENST00000854297, ENST00000854298, ENST00000854299, ENST00000854300, ENST00000854301, ENST00000854302, ENST00000854303, ENST00000854304, ENST00000854305, ENST00000854306, ENST00000854307, ENST00000854308, ENST00000854309, ENST00000854310, ENST00000854311, ENST00000854312, ENST00000854313, ENST00000854314, ENST00000854315, ENST00000854316, ENST00000854317, ENST00000854318, ENST00000920492, ENST00000920493, ENST00000920494, ENST00000920495, ENST00000920496, ENST00000920497, ENST00000920498, ENST00000920499, ENST00000920500, ENST00000920501, ENST00000920502, ENST00000920503, ENST00000920504, ENST00000920505, ENST00000920506, ENST00000920507, ENST00000920508, ENST00000920509, ENST00000920510, ENST00000920511, ENST00000920512, ENST00000920513, ENST00000920514, ENST00000920515, ENST00000959733, ENST00000959734, ENST00000959735, ENST00000959736, ENST00000959737, ENST00000959738
RefSeq mRNA: 7 — MANE Select: NM_001184989
NM_001184986, NM_001184987, NM_001184988, NM_001184989, NM_001184990, NM_001184991, NM_002494
CCDS: CCDS3746
Canonical transcript exons
ENST00000394223 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001517793 | 139289931 | 139290092 |
| ENSE00001517794 | 139302416 | 139302477 |
| ENSE00002058322 | 139297385 | 139297443 |
| ENSE00003527591 | 139292530 | 139292609 |
| ENSE00003532122 | 139295043 | 139295146 |
| ENSE00003532724 | 139295732 | 139295960 |
Expression profiles
Bgee: expression breadth ubiquitous, 294 present calls, max score 99.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 135.4493 / max 728.1735, expressed in 1827 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 54058 | 123.5371 | 1826 |
| 54062 | 7.7957 | 1723 |
| 54061 | 1.7328 | 886 |
| 54060 | 1.5668 | 712 |
| 54063 | 0.5400 | 292 |
| 54059 | 0.2768 | 95 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| renal medulla | UBERON:0000362 | 99.46 | gold quality |
| heart right ventricle | UBERON:0002080 | 99.42 | gold quality |
| diaphragm | UBERON:0001103 | 99.28 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 99.27 | gold quality |
| biceps brachii | UBERON:0001507 | 99.19 | gold quality |
| type B pancreatic cell | CL:0000169 | 99.16 | gold quality |
| body of tongue | UBERON:0011876 | 99.13 | gold quality |
| nephron tubule | UBERON:0001231 | 99.08 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 99.08 | gold quality |
| vastus lateralis | UBERON:0001379 | 99.03 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 98.90 | gold quality |
| vena cava | UBERON:0004087 | 98.84 | gold quality |
| tongue | UBERON:0001723 | 98.81 | gold quality |
| triceps brachii | UBERON:0001509 | 98.76 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 98.73 | gold quality |
| cardia of stomach | UBERON:0001162 | 98.71 | gold quality |
| renal glomerulus | UBERON:0000074 | 98.66 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 98.66 | gold quality |
| hair follicle | UBERON:0002073 | 98.65 | gold quality |
| cervix epithelium | UBERON:0004801 | 98.64 | gold quality |
| cardiac ventricle | UBERON:0002082 | 98.59 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 98.58 | gold quality |
| pylorus | UBERON:0001166 | 98.57 | gold quality |
| cerebellar vermis | UBERON:0004720 | 98.57 | gold quality |
| adult organism | UBERON:0007023 | 98.57 | gold quality |
| heart left ventricle | UBERON:0002084 | 98.56 | gold quality |
| pons | UBERON:0000988 | 98.55 | gold quality |
| postcentral gyrus | UBERON:0002581 | 98.54 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 98.53 | gold quality |
| superior surface of tongue | UBERON:0007371 | 98.50 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-10 | yes | 33.65 |
| E-MTAB-6701 | yes | 16.45 |
| E-GEOD-135922 | yes | 9.19 |
| E-MTAB-6819 | no | 827.01 |
| E-CURD-97 | no | 331.27 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
19 targeting NDUFC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-5580-5P | 99.38 | 66.96 | 1139 |
| HSA-MIR-520A-5P | 99.35 | 66.72 | 1632 |
| HSA-MIR-525-5P | 99.35 | 66.85 | 1615 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-5690 | 99.25 | 67.58 | 1012 |
| HSA-MIR-4705 | 99.10 | 69.10 | 1091 |
| HSA-MIR-421 | 98.90 | 67.04 | 1883 |
| HSA-MIR-6074 | 98.89 | 69.64 | 2187 |
| HSA-MIR-12125 | 98.59 | 67.54 | 1044 |
| HSA-MIR-1322 | 97.98 | 68.96 | 625 |
| HSA-MIR-9851-5P | 97.57 | 67.49 | 1067 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 16.5% of screened cell lines.
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ndufc1 | ENSMUSG00000037152 |
| rattus_norvegicus | Ndufc1 | ENSRNOG00000089477 |
Protein
Protein identifiers
NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial — O43677 (reviewed: O43677)
Alternative names: Complex I-KFYI, NADH-ubiquinone oxidoreductase KFYI subunit
All UniProt accessions (2): O43677, A0A6Q8PHK7
UniProt curated annotations — full annotation on UniProt →
Function. Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone.
Subunit / interactions. Complex I is composed of 45 different subunits.
Subcellular location. Mitochondrion inner membrane.
Similarity. Belongs to the complex I NDUFC1 subunit family.
RefSeq proteins (7): NP_001171915, NP_001171916, NP_001171917, NP_001171918, NP_001171919, NP_001171920, NP_002485 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026192 | NDUFC1 | Family |
Pfam: PF15088
UniProt features (3 total): transit peptide 1, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
7 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9I4I | ELECTRON MICROSCOPY | 2.63 |
| 9TI4 | ELECTRON MICROSCOPY | 2.66 |
| 9CWT | ELECTRON MICROSCOPY | 3.44 |
| 5XTC | ELECTRON MICROSCOPY | 3.7 |
| 5XTD | ELECTRON MICROSCOPY | 3.7 |
| 5XTH | ELECTRON MICROSCOPY | 3.9 |
| 5XTI | ELECTRON MICROSCOPY | 17.4 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O43677-F1 | 83.60 | 0.50 |
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-611105 | Respiratory electron transport |
| R-HSA-6799198 | Complex I biogenesis |
| R-HSA-1428517 | Aerobic respiration and respiratory electron transport |
| R-HSA-1430728 | Metabolism |
MSigDB gene sets: 235 (showing top):
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN, MODULE_77, MORF_HDAC1, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, MORF_HDAC2, GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS, CAGCTG_AP4_Q5, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY, GOBP_ATP_BIOSYNTHETIC_PROCESS, GOBP_OXIDATIVE_PHOSPHORYLATION, GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS
GO Biological Process (4): mitochondrial electron transport, NADH to ubiquinone (GO:0006120), aerobic respiration (GO:0009060), proton motive force-driven mitochondrial ATP synthesis (GO:0042776), proton transmembrane transport (GO:1902600)
GO Molecular Function (1): NADH dehydrogenase (ubiquinone) activity (GO:0008137)
GO Cellular Component (4): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), respiratory chain complex I (GO:0045271), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Aerobic respiration and respiratory electron transport | 1 |
| Respiratory electron transport | 1 |
| Metabolism | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| aerobic electron transport chain | 1 |
| mitochondrial ATP synthesis coupled electron transport | 1 |
| cellular respiration | 1 |
| mitochondrion | 1 |
| oxidative phosphorylation | 1 |
| proton motive force-driven ATP synthesis | 1 |
| monoatomic cation transmembrane transport | 1 |
| NADH dehydrogenase activity | 1 |
| electron transfer activity | 1 |
| proton transmembrane transporter activity | 1 |
| oxidoreduction-driven active transmembrane transporter activity | 1 |
| oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 1 |
| active monoatomic ion transmembrane transporter activity | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| NADH dehydrogenase complex | 1 |
| respiratory chain complex | 1 |
| transmembrane transporter complex | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
944 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NDUFC1 | NDUFB5 | O43674 | 902 |
| NDUFC1 | NDUFA5 | Q16718 | 900 |
| NDUFC1 | NDUFA2 | O43678 | 881 |
| NDUFC1 | NDUFB3 | O43676 | 870 |
| NDUFC1 | NDUFV3 | P56181 | 846 |
| NDUFC1 | NDUFC2 | O95298 | 836 |
| NDUFC1 | NDUFV2 | P19404 | 826 |
| NDUFC1 | NDUFA6 | P56556 | 810 |
| NDUFC1 | NDUFS6 | O75380 | 798 |
| NDUFC1 | NDUFV1 | P49821 | 755 |
| NDUFC1 | NDUFS1 | P28331 | 753 |
| NDUFC1 | NDUFA7 | O95182 | 722 |
| NDUFC1 | NDUFB2 | O95178 | 721 |
| NDUFC1 | NDUFA12 | Q9UI09 | 672 |
| NDUFC1 | NDUFB6 | O95139 | 660 |
IntAct
0 interactions, top by confidence:
BioGRID (4): NDUFC1 (Affinity Capture-RNA), NDUFC1 (Negative Genetic), NDUFC1 (Negative Genetic), NDUFC1 (Negative Genetic)
ESM2 similar proteins: A0JMH2, A0PJW6, A5PJW2, B3DI94, B5DFG1, O43677, P0CB69, P0CB70, Q059A4, Q0MQF5, Q0MQF6, Q0V9C9, Q0VCH8, Q13405, Q3SX05, Q3SZA2, Q3SZV6, Q3U6U5, Q4G012, Q4KLZ1, Q4KM93, Q4R5K7, Q4R5Q4, Q4VAE3, Q53S58, Q5EA71, Q5R8X0, Q5XIC2, Q66LN0, Q6DC58, Q6PI78, Q75CX4, Q80YU0, Q863F8, Q863G5, Q8BPE4, Q8BWM0, Q8N159, Q8R4H7, Q95SS8
Diamond homologs: O43677, P0CB69, P0CB70, Q02376, Q0MQF5, Q0MQF6, Q9CQY9
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| NDUFC1 | “form complex” | “NADH-ubiquinone oxidoreductase-Mitochondrial respiratory chain complex I” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 14 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1738 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:139275287:A:AC | donor_gain | 1.0000 |
| 4:139275288:C:CC | donor_gain | 1.0000 |
| 4:139275391:TG:T | acceptor_gain | 1.0000 |
| 4:139275392:GCT:G | acceptor_loss | 1.0000 |
| 4:139275393:C:CC | acceptor_gain | 1.0000 |
| 4:139275393:C:T | acceptor_loss | 1.0000 |
| 4:139292528:A:AC | donor_gain | 1.0000 |
| 4:139292529:C:CC | donor_gain | 1.0000 |
| 4:139292529:CTA:C | donor_gain | 1.0000 |
| 4:139292529:CTACA:C | donor_gain | 1.0000 |
| 4:139292606:TGAG:T | acceptor_gain | 1.0000 |
| 4:139292607:GAGCT:G | acceptor_loss | 1.0000 |
| 4:139292608:AGC:A | acceptor_loss | 1.0000 |
| 4:139292609:GCTAC:G | acceptor_loss | 1.0000 |
| 4:139292610:C:CA | acceptor_loss | 1.0000 |
| 4:139292610:C:CC | acceptor_gain | 1.0000 |
| 4:139295041:A:AC | donor_gain | 1.0000 |
| 4:139295042:C:CC | donor_gain | 1.0000 |
| 4:139295142:TGAAG:T | acceptor_gain | 1.0000 |
| 4:139295143:GAAG:G | acceptor_gain | 1.0000 |
| 4:139295144:AAG:A | acceptor_gain | 1.0000 |
| 4:139295145:AG:A | acceptor_gain | 1.0000 |
| 4:139295147:C:CC | acceptor_gain | 1.0000 |
| 4:139301829:TTGGT:T | donor_loss | 1.0000 |
| 4:139301830:TGG:T | donor_loss | 1.0000 |
| 4:139301831:GGT:G | donor_loss | 1.0000 |
| 4:139301832:G:GA | donor_loss | 1.0000 |
| 4:139301832:G:GG | donor_gain | 1.0000 |
| 4:139268667:TTTA:T | donor_loss | 0.9900 |
| 4:139268668:TTACC:T | donor_loss | 0.9900 |
AlphaMissense
471 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:139295051:A:G | W55R | 0.973 |
| 4:139295051:A:T | W55R | 0.973 |
| 4:139295069:C:G | G49R | 0.969 |
| 4:139295127:G:C | F29L | 0.959 |
| 4:139295127:G:T | F29L | 0.959 |
| 4:139295129:A:G | F29L | 0.959 |
| 4:139295068:C:T | G49D | 0.951 |
| 4:139295059:A:T | V52D | 0.940 |
| 4:139295093:A:G | W41R | 0.904 |
| 4:139295093:A:T | W41R | 0.904 |
| 4:139295080:C:T | G45E | 0.893 |
| 4:139295081:C:G | G45R | 0.893 |
| 4:139295081:C:T | G45R | 0.893 |
| 4:139295091:C:A | W41C | 0.886 |
| 4:139295091:C:G | W41C | 0.886 |
| 4:139292575:T:G | Y69S | 0.885 |
| 4:139292608:A:G | L58P | 0.867 |
| 4:139292565:T:A | R72S | 0.862 |
| 4:139292565:T:G | R72S | 0.862 |
| 4:139292572:T:A | K70I | 0.862 |
| 4:139295049:C:A | W55C | 0.862 |
| 4:139295049:C:G | W55C | 0.862 |
| 4:139292576:A:G | Y69H | 0.855 |
| 4:139292576:A:C | Y69D | 0.844 |
| 4:139292579:C:T | E68K | 0.821 |
| 4:139292596:T:G | H62P | 0.807 |
| 4:139292577:C:A | E68D | 0.791 |
| 4:139292577:C:G | E68D | 0.791 |
| 4:139292575:T:C | Y69C | 0.789 |
| 4:139295083:A:T | V44D | 0.780 |
dbSNP variants (sampled 300 via entrez): RS1000108485 (4:139294808 T>A,C), RS1000124112 (4:139304103 A>G), RS10003164 (4:139296482 C>T), RS1000410436 (4:139302930 T>C), RS1000449463 (4:139301439 A>G), RS1000621992 (4:139290895 G>C), RS1000903599 (4:139296962 C>G,T), RS1000976249 (4:139290740 C>A,T), RS1001512985 (4:139291880 A>G), RS1001554956 (4:139298296 G>A), RS1001683099 (4:139301764 G>A,T), RS1001943175 (4:139303460 A>C,G), RS1002085387 (4:139294048 T>G), RS1002113010 (4:139298075 A>G), RS1002139251 (4:139293767 C>G,T)
Disease associations
OMIM: gene MIM:603844 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL2363065 (PROTEIN COMPLEX)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
8 potent at pChembl≥5 of 18 total, top 8 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 6.06 | IC50 | 870 | nM | R-(+)-MARMIN-6’-UNDECANOATE |
| 6.04 | IC50 | 920 | nM | R-(+)-MARMIN-6’-LINOLEATE |
| 5.63 | IC50 | 2350 | nM | R-(+)-MARMIN-6’-LINOLEATE |
| 5.51 | IC50 | 3080 | nM | R-(+)-MARMIN-6’-OCTANOATE |
| 5.43 | IC50 | 3670 | nM | R-(+)-MARMIN-6’-UNDECANOATE |
| 5.43 | IC50 | 3710 | nM | R-(+)-MARMIN-6’-OCTANOATE |
| 5.31 | IC50 | 4900 | nM | (+)-9’-ISOVALEROXYLARICIRESINOL |
| 5.04 | IC50 | 9100 | nM | (+)-9’-ISOVALEROXYLARICIRESINOL |
PubChem BioAssay actives
8 with measured affinity, of 28 total; 4 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| [(E,3R)-2-hydroxy-2,6-dimethyl-8-(2-oxochromen-7-yl)oxyoct-6-en-3-yl] undecanoate | 739270: Inhibition of mitochondrial ETC complex 1 in human T47D cells assessed as inhibition of 1% O2-induced HIF1 activation incubated for 30 mins prior to 1% O2-challenge measured after 16 hrs by luciferase reporter assay | ic50 | 0.8700 | uM |
| [(E,3R)-2-hydroxy-2,6-dimethyl-8-(2-oxochromen-7-yl)oxyoct-6-en-3-yl] (9Z,12Z)-octadeca-9,12-dienoate | 739270: Inhibition of mitochondrial ETC complex 1 in human T47D cells assessed as inhibition of 1% O2-induced HIF1 activation incubated for 30 mins prior to 1% O2-challenge measured after 16 hrs by luciferase reporter assay | ic50 | 0.9200 | uM |
| [(E,3R)-2-hydroxy-2,6-dimethyl-8-(2-oxochromen-7-yl)oxyoct-6-en-3-yl] octanoate | 739270: Inhibition of mitochondrial ETC complex 1 in human T47D cells assessed as inhibition of 1% O2-induced HIF1 activation incubated for 30 mins prior to 1% O2-challenge measured after 16 hrs by luciferase reporter assay | ic50 | 3.0800 | uM |
| [(2S,3R,4R)-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methyl 3-methylbutanoate | 739269: Inhibition of mitochondrial ETC complex 1 in human T47D cells assessed as inhibition of 1,10-phenanthroline-induced HIF1 activation incubated for 30 mins prior to 1,10-phenanthroline-challenge measured after 16 hrs by luciferase reporter assay | ic50 | 4.9000 | uM |
CTD chemical–gene interactions
40 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, decreases expression, increases expression | 3 |
| Acetaminophen | decreases expression, affects cotreatment | 2 |
| Air Pollutants | increases expression, affects expression, affects cotreatment, increases abundance | 2 |
| Ozone | affects cotreatment, increases expression, increases abundance, affects expression | 2 |
| alpha-pinene | affects cotreatment, increases expression, increases abundance | 1 |
| sodium arsenite | increases expression | 1 |
| ochratoxin A | increases expression | 1 |
| methacrylaldehyde | affects cotreatment, increases expression, increases abundance | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| corosolic acid | decreases expression | 1 |
| K 7174 | decreases expression | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| Acrolein | affects cotreatment, increases expression, increases abundance | 1 |
| Vehicle Emissions | increases expression, increases abundance | 1 |
| Camptothecin | increases expression | 1 |
| Carmustine | decreases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Dietary Carbohydrates | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Fluorouracil | affects expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Nickel | decreases expression | 1 |
| Niclosamide | increases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Tunicamycin | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
ChEMBL screening assays
4 unique, capped per target: 4 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL2353025 | Binding | Inhibition of mitochondrial ETC complex 1 in human T47D cells assessed as inhibition of 1% O2-induced HIF1 activation at 30 uM incubated for 30 mins prior to 1% O2-challenge measured after 16 hrs by luciferase reporter assay | Semisynthetic studies identify mitochondria poisons from botanical dietary supplements–geranyloxycoumarins from Aegle marmelos. — Bioorg Med Chem |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3C5 | Abcam HEK293T NDUFC1 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.